Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Discovery
Cancer Discovery

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
    • Journal Press Releases

More articles from News in Depth

  • Warming “Cold” Melanoma with TLR9 Agonists
    Cancer Discovery Apr 2018, DOI: 10.1158/2159-8290.CD-ND2018-004
  • STINGing Antitumor Immunity into Action
    Cancer Discovery Mar 2018, 8 (3) 259-260; DOI: 10.1158/2159-8290.CD-ND2018-002
  • Venetoclax Data Prompt Rethink of CLL Therapy
    Cancer Discovery Mar 2018, 8 (3) OF5; DOI: 10.1158/2159-8290.CD-ND2018-003
  • Gut Bacteria Shape Therapeutic Response
    Cancer Discovery Feb 2018, 8 (2) 134; DOI: 10.1158/2159-8290.CD-ND2018-001
  • Checkpoint Inhibitors Spur Changes in Trial Design
    Cancer Discovery Nov 2017, 7 (11) 1209-1210; DOI: 10.1158/2159-8290.CD-ND2017-006
  • Taking the Guesswork Out of Stopping TKIs
    Cancer Discovery Sep 2017, 7 (9) 928; DOI: 10.1158/2159-8290.CD-ND2017-005
  • Why First-Line Nivolumab Is No Better than Chemo
    Cancer Discovery Sep 2017, 7 (9) 927; DOI: 10.1158/2159-8290.CD-ND2017-004
  • Chromosome Instability Drives Tumor Evolution
    Cancer Discovery Jun 2017, 7 (6) 546; DOI: 10.1158/2159-8290.CD-ND2017-003
  • Converging on RAS
    Cancer Discovery May 2017, 7 (5) 449; DOI: 10.1158/2159-8290.CD-ND2017-001
  • Surge in Philanthropy Fuels Cancer Research
    Cancer Discovery Jan 2017, 7 (1) 8; DOI: 10.1158/2159-8290.CD-ND2016-008

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 13
  • Home
  • Alerts
  • Feedback
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement